{"id":"https://openalex.org/W4240940425","doi":"https://doi.org/10.1182/blood.v106.11.4765.4765","title":"A Phase II Trial of CHOP Chemotherapy Followed by Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.","display_name":"A Phase II Trial of CHOP Chemotherapy Followed by Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.","publication_year":2005,"publication_date":"2005-11-16","ids":{"openalex":"https://openalex.org/W4240940425","doi":"https://doi.org/10.1182/blood.v106.11.4765.4765"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v106.11.4765.4765","doi":"https://doi.org/10.1182/blood.v106.11.4765.4765","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v106.11.4765.4765","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091882595","display_name":"Pier Luigi Zinzani","orcid":"https://orcid.org/0000-0002-2112-2651","observed_orcids":["https://orcid.org/0000-0002-2112-2651"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pier Luigi Zinzani","raw_affiliation_strings":["1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017472528","display_name":"Monica Tani","orcid":"https://orcid.org/0000-0002-5016-2054","observed_orcids":["https://orcid.org/0000-0002-5016-2054"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Monica Tani","raw_affiliation_strings":["1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039739851","display_name":"Vittorio Stefoni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vittorio Stefoni","raw_affiliation_strings":["1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054730003","display_name":"Lapo Alinari","orcid":"https://orcid.org/0000-0002-8870-4162","observed_orcids":["https://orcid.org/0000-0002-8870-4162"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lapo Alinari","raw_affiliation_strings":["1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102738050","display_name":"Enrica Marchi","orcid":"https://orcid.org/0000-0002-6661-9119","observed_orcids":["https://orcid.org/0000-0002-6661-9119"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Enrica Marchi","raw_affiliation_strings":["1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114007920","display_name":"Mariapaola Fina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mariapaola Fina","raw_affiliation_strings":["1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044224344","display_name":"Michele Baccarani","orcid":"https://orcid.org/0000-0003-1999-1687","observed_orcids":["https://orcid.org/0000-0003-1999-1687"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Michele Baccarani","raw_affiliation_strings":["1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Hematology and Oncology \u201cSera\u0300gnoli\u201d, University of Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I9360294"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.6417,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.72238938,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"106","issue":"11","first_page":"4765","last_page":"4765"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zevalin","display_name":"Zevalin","score":0.8529999852180481},{"id":"https://openalex.org/keywords/chop-chemotherapy","display_name":"CHOP chemotherapy","score":0.7630000114440918},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9330000281333923},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9879999756813049},{"id":"https://openalex.org/keywords/previously-untreated-lymphoma","display_name":"previously untreated lymphoma","score":0.8100000023841858},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.7099999785423279},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.921999990940094},{"id":"https://openalex.org/keywords/consolidation-therapy","display_name":"consolidation therapy","score":0.8899999856948853},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.7210000157356262},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.5090000033378601},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.6019999980926514},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.32499998807907104},{"id":"https://openalex.org/keywords/hematopoietic-toxicity","display_name":"hematopoietic toxicity","score":0.4410000145435333}],"concepts":[{"id":"https://openalex.org/C2778515704","wikidata":"https://www.wikidata.org/wiki/Q635415","display_name":"Ibritumomab tiuxetan","level":5,"score":0.9459710121154785},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8126821517944336},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.6213511228561401},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5403435826301575},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.5198086500167847},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5188961625099182},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.49187541007995605},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.48520615696907043},{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.4671613276004791},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41539251804351807},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4012404978275299},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.36565685272216797},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3418410122394562},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1525912582874298},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.05616992712020874},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v106.11.4765.4765","doi":"https://doi.org/10.1182/blood.v106.11.4765.4765","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v106.11.4765.4765","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2045209749","https://openalex.org/W4249693472","https://openalex.org/W2556290127","https://openalex.org/W2127249281","https://openalex.org/W2559637800","https://openalex.org/W4255342149","https://openalex.org/W2537681527","https://openalex.org/W2555963297","https://openalex.org/W2603119644","https://openalex.org/W2979579728"],"abstract_inverted_index":{"Abstract":[0],"In":[1],"the":[2,6,10,16,60,78,115,132,188,219,238,247,274,302,309,315,320],"last":[3],"20":[4,362],"years,":[5],"major":[7],"improvement":[8],"over":[9],"use":[11],"of":[12,18,63,80,98,105,118,136,140,193,202,210,218,222,240,273,277,290,322,341,354,361,370],"CHOP":[13,149,256,278,291,323],"has":[14,51],"been":[15,52,365],"addition":[17],"anti-CD20":[19],"immunotherapy":[20],"(Rituximab).":[21],"This":[22],"advancement":[23],"was":[24,166,244,305],"first":[25],"demonstrated":[26,53,325],"in":[27,31,43,54,77,109,114,232],"a":[28,64,102,123,141,197,207,227,284,338,351],"randomized":[29],"trial":[30,67,372],"elderly":[32,82,119,162],"patients":[33,158,169,215,334,363],"with":[34,91,111,148,153,159,174,234,254,297,331],"diffuse":[35],"large":[36],"B-cell":[37],"lymphoma":[38],"(DLBCL).":[39],"Single-agent":[40],"radioimmunotherapy":[41],"activity,":[42],"particular":[44],"Yttrium":[45],"90":[46],"(90Y)":[47],"Ibritumomab":[48,72,107,138,155,299,343],"Tiuxetan":[49,73,108,139,156,300,344],"(Zevalin),":[50],"heavily":[55],"pretreated":[56],"DLBCL":[57,83,186],"patients.":[58],"Recently,":[59],"preliminary":[61,368],"data":[62],"phase":[65,128],"II":[66,129],"have":[68,74,364],"showed":[69],"that":[70],"90Y":[71,106,137,154,298,342],"useful":[75],"activity":[76],"treatment":[79],"relapsed/refractory":[81],"(Morschhauser":[84],"et":[85],"al,":[86],"Blood":[87],"2004,":[88],"104:":[89],"41a),":[90],"no":[92,326],"unexpected":[93],"toxicities":[94],"observed.":[95],"The":[96,242],"results":[97,369],"this":[99,223,371],"study":[100,224,243],"support":[101],"further":[103],"evaluation":[104],"combination":[110],"chemotherapy":[112,147,257,292,324],"earlier":[113],"time":[116],"course":[117],"DLBCL.":[120,163],"We":[121],"conducted":[122],"prospective,":[124],"single-arm,":[125],"open-label,":[126],"non-randomized,":[127],"to":[130,195,268,336,350],"evaluate":[131],"efficacy":[133],"and":[134,206,225,314,367],"safety":[135],"novel":[142],"new":[143],"approach":[144],"combining":[145],"induction":[146],"followed":[150],"by":[151,246],"consolidation":[152,296],"for":[157,261,295],"previously":[160],"untreated":[161],"Patient":[164],"eligibility":[165],"represented":[167],"by:":[168],"older":[170],"than":[171,307,328],"60":[172],"years":[173],"biopsy-proven,":[175],"untreated,":[176],"bidimensionally":[177],"measurable":[178],"stage":[179,181,184],"II,":[180],"III,":[182],"or":[183,204,212],"IV":[185],"expressing":[187],"CD20":[189],"antigen;":[190],"performance":[191],"status":[192],"0":[194],"2,":[196],"pretreatment":[198],"granulocyte":[199,303],"cell":[200],"count":[201,209,304,311],"1500/\u03bcL":[203],"greater,":[205],"platelet":[208,310],"100.000/\u03bcL":[211],"greater.":[213],"All":[214,333],"were":[216,252,265,293,335],"notified":[217],"investigational":[220],"nature":[221],"signed":[226],"written":[228],"informed":[229],"consent":[230],"approved":[231,245],"accordance":[233],"institutional":[235,248],"guidelines,":[236],"including":[237],"Declaration":[239],"Helsinki.":[241],"review":[249],"board.":[250],"Patients":[251,264,280],"treated":[253],"standard":[255],"every":[258],"21":[259],"days":[260],"6":[262,288],"cycles.":[263],"restaged":[266],"4":[267],"8":[269],"weeks":[270],"after":[271,287],"completion":[272,321],"sixth":[275],"cycle":[276],"chemotherapy.":[279],"achieving":[281],"at":[282,319],"least":[283],"partial":[285],"response":[286],"cycles":[289],"eligible":[294],"provided":[301],"greater":[306],"1500/\u03bcL,":[308],"exceeded":[312],"100.000/\u03bcL,":[313],"bone":[316],"marrow":[317],"examination":[318],"more":[327],"25%":[329],"involvement":[330],"lymphoma.":[332],"receive":[337],"single":[339],"dose":[340,353],"14.8":[345],"MBq/kg":[346],"(0.4":[347],"mCi/kg)":[348],"up":[349],"maximum":[352],"1184":[355],"MBq":[356],"(32":[357],"mCi).":[358],"A":[359],"total":[360],"enrolled":[366],"will":[373],"be":[374],"presented.":[375]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}